Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Surgery Partners, Inc. SGRY

Full chart Compare
Set alert

Price alert · SGRY

All alert types
23.13 USD +0.01 (+0.04%)

At closeNov 4, 2026, 7:00 AM EST

23.41 +0.28 +1.21%

Pre-market · Nov 4, 7:00 AM ET

23.12 Day range 23.22
11.41 52-week range 23.37
YTD
+49.71%
1 year
+5.14%

Financial health

Altman Z-Score

1.03 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -25.3×
FY 2016: 79.3×FY 2017: -11.1×FY 2018: -2.3×FY 2019: -6.8×FY 2020: -9.1×FY 2021: -47.7×FY 2022: -47.2×FY 2023: -338×FY 2024: -15.9×FY 2025: -25.3×
FY 2016 5y median -47.2× FY 2025
P/S 0.6×
FY 2016: 0.7×FY 2017: 0.4×FY 2018: 0.3×FY 2019: 0.4×FY 2020: 0.8×FY 2021: 1.7×FY 2022: 1.0×FY 2023: 1.5×FY 2024: 0.9×FY 2025: 0.6×
FY 2016 5y median 1.0× FY 2025
P/B 1.1×
FY 2016: 78.7×FY 2017: 0.9×FY 2018: 1.2×FY 2019: 1.1×FY 2020: 2.6×FY 2021: 3.6×FY 2022: 1.3×FY 2023: 2.0×FY 2024: 1.5×FY 2025: 1.1×
FY 2016 5y median 1.5× FY 2025
P/FCF 10.0×
FY 2016: 8.8×FY 2017: 6.4×FY 2018: 4.5×FY 2019: 13.5×FY 2020: 6.9×FY 2021: 131×FY 2022: 32.8×FY 2023: 19.6×FY 2024: 12.7×FY 2025: 10.0×
FY 2016 5y median 19.6× FY 2025
EV/EBITDA 10.2×
FY 2016: 8.9×FY 2017: 10.3×FY 2018: 19.1×FY 2019: 11.5×FY 2020: 15.5×FY 2021: 16.9×FY 2022: 11.3×FY 2023: 15.4×FY 2024: 12.2×FY 2025: 10.2×
FY 2016 5y median 12.2× FY 2025
EV/Sales 1.7×
FY 2016: 1.9×FY 2017: 1.9×FY 2018: 1.6×FY 2019: 1.9×FY 2020: 2.3×FY 2021: 3.0×FY 2022: 2.1×FY 2023: 2.5×FY 2024: 2.0×FY 2025: 1.7×
FY 2016 5y median 2.1× FY 2025
FCF Yield 10.0%
FY 2016: 11.3%FY 2017: 15.5%FY 2018: 22.3%FY 2019: 7.4%FY 2020: 14.4%FY 2021: 0.8%FY 2022: 3.1%FY 2023: 5.1%FY 2024: 7.9%FY 2025: 10.0%
FY 2016 5y median 5.1% FY 2025

Profitability

Gross Margin 23.1%
FY 2016: 28.3%FY 2017: 24.4%FY 2018: 23.1%FY 2019: 23.1%FY 2020: 20.4%FY 2021: 22.1%FY 2022: 22.6%FY 2023: 23.6%FY 2024: 23.9%FY 2025: 23.1%
FY 2016 5y median 23.1% FY 2025
Operating Margin 11.8%
FY 2016: 17.2%FY 2017: 11.8%FY 2018: 4.4%FY 2019: 12.9%FY 2020: 9.8%FY 2021: 13.6%FY 2022: 13.6%FY 2023: 12.0%FY 2024: 11.2%FY 2025: 11.8%
FY 2016 5y median 12.0% FY 2025
Net Margin -2.4%
FY 2016: 0.8%FY 2017: -4.0%FY 2018: -11.6%FY 2019: -4.1%FY 2020: -6.2%FY 2021: -3.2%FY 2022: -2.2%FY 2023: -0.4%FY 2024: -5.4%FY 2025: -2.4%
FY 2016 5y median -2.4% FY 2025
ROE -4.5%
FY 2016: 97.7%FY 2017: -8.1%FY 2018: -50.8%FY 2019: -10.8%FY 2020: -21.1%FY 2021: -6.5%FY 2022: -2.7%FY 2023: -0.6%FY 2024: -9.4%FY 2025: -4.5%
FY 2016 5y median -4.5% FY 2025
ROIC 4.2%
FY 2016: 8.5%FY 2017: 1.3%FY 2018: 1.8%FY 2019: 4.1%FY 2020: -0.3%FY 2021: 4.6%FY 2022: 4.3%FY 2023: 5.1%FY 2024: 0.4%FY 2025: 4.2%
FY 2016 5y median 4.3% FY 2025
ROA -0.9%
FY 2016: 0.4%FY 2017: -1.1%FY 2018: -4.4%FY 2019: -1.5%FY 2020: -2.1%FY 2021: -1.2%FY 2022: -0.8%FY 2023: -0.2%FY 2024: -2.1%FY 2025: -0.9%
FY 2016 5y median -0.9% FY 2025

Growth (YoY)

Revenue 6.2%
FY 2016: 19.3%FY 2017: 17.1%FY 2018: 32.1%FY 2019: 3.4%FY 2020: 1.6%FY 2021: 19.6%FY 2022: 14.1%FY 2023: 8.0%FY 2024: 13.5%FY 2025: 6.2%
FY 2016 FY 2025
Operating Income 11.7%
FY 2016: 35.7%FY 2017: -19.5%FY 2018: -50.8%FY 2019: 203.1%FY 2020: -22.4%FY 2021: 65.1%FY 2022: 14.2%FY 2023: -5.0%FY 2024: 6.3%FY 2025: 11.7%
FY 2016 FY 2025
EPS (diluted) 54.1%
FY 2016: 400.0%FY 2017: -640.0%FY 2018: -296.3%FY 2019: 46.5%FY 2020: -39.3%FY 2021: 64.9%FY 2022: 47.3%FY 2023: 83.9%FY 2024: -1304.4%FY 2025: 54.1%
FY 2016 FY 2025
Free Cash Flow -6.7%
FY 2016: 68.7%FY 2017: 6.1%FY 2018: 14.7%FY 2019: -46.7%FY 2020: 264.9%FY 2021: -85.5%FY 2022: 165.1%FY 2023: 162.1%FY 2024: 2.3%FY 2025: -6.7%
FY 2016 FY 2025

Financial Health

Current Ratio 1.9×
FY 2016: 1.9×FY 2017: 1.9×FY 2018: 1.7×FY 2019: 1.3×FY 2020: 1.4×FY 2021: 1.8×FY 2022: 1.9×FY 2023: 1.7×FY 2024: 1.8×FY 2025: 1.9×
FY 2016 5y median 1.8× FY 2025
Quick Ratio 1.7×
FY 2016: 1.8×FY 2017: 1.7×FY 2018: 1.6×FY 2019: 1.2×FY 2020: 1.3×FY 2021: 1.6×FY 2022: 1.7×FY 2023: 1.6×FY 2024: 1.7×FY 2025: 1.7×
FY 2016 5y median 1.7× FY 2025
Debt / Equity 2.3×
FY 2016: 155×FY 2017: 3.3×FY 2018: 6.1×FY 2019: 4.2×FY 2020: 5.8×FY 2021: 3.0×FY 2022: 1.5×FY 2023: 1.5×FY 2024: 2.1×FY 2025: 2.3×
FY 2016 5y median 2.1× FY 2025
Net Debt / EBITDA 6.7×
FY 2016: 5.8×FY 2017: 8.0×FY 2018: 15.8×FY 2019: 9.1×FY 2020: 10.4×FY 2021: 7.2×FY 2022: 5.8×FY 2023: 6.4×FY 2024: 6.8×FY 2025: 6.7×
FY 2016 5y median 6.7× FY 2025
Interest Coverage 1.4×
FY 2016: 2.0×FY 2017: 1.3×FY 2018: 0.5×FY 2019: 1.3×FY 2020: 0.9×FY 2021: 1.4×FY 2022: 1.5×FY 2023: 1.7×FY 2024: 1.7×FY 2025: 1.4×
FY 2016 5y median 1.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.2%FY 2018: 1.7%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.1%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: -2.5%FY 2018: -3.8%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -7.2%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31